Establishing a novel knock-in mouse line for studying neuronal cytoplasmic dynein under normal and pathologic conditions

Cytoskeleton

Volumn 70, Issue 4, 2013, Pages 215-227

  Zhang, Jun ^a   Twelvetrees, Alison E ^b   Lazarus, Jacob E ^b   Blasier, Kiev R ^c   Yao, Xuanli ^a   Inamdar, Nirja A ^c   Holzbaur, Erika L F ^b   Pfister, K Kevin ^c   Xiang, Xin ^a  

^a UNIFORMED SERVICES UNIVERSITY OF THE HEALTH SCIENCES   (United States)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

^c UNIVERSITY OF VIRGINIA   (United States)

Author keywords

Cytoplasmic dynein; Knock in mouse; Neuron; Transport, brain injury

Indexed keywords

CYTOPLASMIC DYNEIN; DYNACTIN; GREEN FLUORESCENT PROTEIN; INTERMEDIATE CHAIN 1; PROTEIN TAG; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; BINDING AFFINITY; BRAIN CORTEX; CARBOXY TERMINAL SEQUENCE; CELL ISOLATION; COMPLEX FORMATION; CYTOLOGY; FUSION GENE; GENE LOCUS; GENE TARGETING; MOUSE; NERVE CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN INTERACTION; TRAUMATIC BRAIN INJURY;

ANIMALS; BRAIN; CYTOPLASMIC DYNEINS; DYNEINS; FEMALE; GENE KNOCK-IN TECHNIQUES; HUMANS; MALE; MICE; MICE, INBRED C57BL; MICE, TRANSGENIC; NEURONS; PREGNANCY;

EID: 84876312705     PISSN: 19493584     EISSN: 19493592     Source Type: Journal    
DOI: 10.1002/cm.21102     Document Type: Article

References (95)

1. Abe N, Cavalli V. 2008. Nerve injury signaling. Curr Opin Neurobiol 18:276-283.
2. Akhmanova A, Hammer JA, 3rd. 2010. Linking molecular motors to membrane cargo. Curr Opin Cell Biol 22:479-487.
3. Banker G, Goslin K. 1998. Culturing Nerve Cells. Cambridge, MA: The MIT Press.
4. Banks GT, Haas MA, Line S, Shepherd HL, Alqatari M, Stewart S, Rishal I, Philpott A, Kalmar B, Kuta A, Groves M, Parkinson N, Acevedo-Arozena A, Brandner S, Bannerman D, Greensmith L, Hafezparast M, Koltzenburg M, Deacon R, Fainzilber M, Fisher EM. 2011. Behavioral and other phenotypes in a cytoplasmic dynein light intermediate chain 1 mutant mouse. J Neurosci 31:5483-5494.
5. Bass PW, Buster DW. 2004. Slow axonal transport and genesis and neuronal morphology. J Neurobiol 58:3-17.
6. Budinich CS, Chen H, Lowe D, Rosenberger JG, Bernstock JD, McCabe JT. 2012. Mouse brain PSA-NCAM levels are altered by graded-controlled cortical impact injury. Neural Plast. 2012:13.
7. Cavalli V, Kujala P, Klumperman J, Goldstein LS. 2005. Sunday driver links axonal transport to damage signaling. J Cell Biol 168:775-787.
8. Cheah PS, Ramshaw HS, Thomas PQ, Toyo-Oka K, Xu X, Martin S, Coyle P, Guthridge MA, Stomski F, van den Buuse M, Wynshaw-Boris A, Lopez AF, Schwarz QP. 2012. Neurodevelopmental and neuropsychiatric behaviour defects arise from 14-3-3zeta deficiency. Mol Psychiatry 17:451-466.
9. Chen L, Wang Z, Ghosh-Roy A, Hubert T, Yan D, O'Rourke S, Bowerman B, Wu Z, Jin Y, Chisholm AD. 2011. Axon regeneration pathways identified by systematic genetic screening in C. elegans. Neuron 71:1043-1057.
10. Chen XJ, Levedakou EN, Millen KJ, Wollmann RL, Soliven B, Popko B. 2007. Proprioceptive sensory neuropathy in mice with a mutation in the cytoplasmic dynein heavy chain 1 gene. J Neurosci 27:14515-14524.
11. Chevalier-Larsen ES, Wallace KE, Pennise CR, Holzbaur EL. 2008. Lysosomal proliferation and distal degeneration in motor neurons expressing the G59S mutation in the p150Glued subunit of dynactin. Human Mol Genet 17:1946-1955.
12. Cosker KE, Courchesne SL, Segal RA. 2008. Action in the axon: Generation and transport of signaling endosomes. Curr Opin Neurobiol 18:270-275.
13. Dai JG, Murakami K. 2003. Constitutively and autonomously active protein kinase c associated with 14-3-3 zeta in the rodent brain. J Neurochem. 84:23-34.
14. Dillman JF, 3rd, Pfister KK. 1994. Differential phosphorylation in vivo of cytoplasmic dynein associated with anterogradely moving organelles. J Cell Biol 127:1671-1681.
15. Encalada SE, Szpankowski L, Xia CH, Goldstein LS. 2011. Stable kinesin and dynein assemblies drive the axonal transport of mammalian prion protein vesicles. Cell 144:551-565.
16. Farrer MJ, Hulihan MM, Kachergus JM, Dachsel JC, Stoessl AJ, Grantier LL, Calne S, Calne DB, Lechevalier B, Chapon F, Tsuboi Y, Yamada T, Gutmann L, Elibol B, Bhatia KP, Wider C, Vilariño-Güell C, Ross OA, Brown LA, Castanedes-Casey M, Dickson DW, Wszolek ZK. 2009. DCTN1 mutations in Perry syndrome. Nat Genet 41:163-165.
17. Ghosh-Roy A, Goncharov A, Jin Y, Chisholm AD. 2012. Kinesin-13 and tubulin posttranslational modifications regulate microtubule growth in axon regeneration. Dev Cell 23:716-728.
18. Gomis-Ruth S, Wierenga CJ, Bradke F. 2008. Plasticity of polarization: Changing dendrites into axons in neurons integrated in neuronal circuits. Curr Biol 18:992-1000.
19. Ha J, Lo KW, Myers KR, Carr TM, Humsi MK, Rasoul BA, Segal RA, Pfister KK. 2008. A neuron-specific cytoplasmic dynein isoform preferentially transports TrkB signaling endosomes. J Cell Biol 181:1027-1039.
20. Habura A, Tikhonenko I, Chisholm RL, Koonce MP. 1999. Interaction mapping of a dynein heavy chain. Identification of dimerization and intermediate-chain binding domains. J Biol Chem 274:15447-15453.
21. Harada A, Takei Y, Kanai Y, Tanaka Y, Nonaka S, Hirokawa N. 1998. Golgi vesiculation and lysosome dispersion in cells lacking cytoplasmic dynein. J Cell Biol 141:51-59.
22. Harms MB, Ori-McKenney KM, Scoto M, Tuck EP, Bell S, Ma D, Masi S, Allred P, Al-Lozi M, Reilly MM, Miller LJ, Jani-Acsadi A, Pestronk A, Shy ME, Muntoni F, Vallee RB, Baloh RH. 2012. Mutations in the tail domain of dync1h1 cause dominant spinal muscular atrophy. Neurology 78:1714-1720.
23. Heerssen HM, Pazyra MF, Segal RA. 2004. Dynein motors transport activated Trks to promote survival of target-dependent neurons. Nat Neurosci 7:596-604.
24. Höök P, Vallee R. 2012. Dynein dynamics. Nat Struct Mol Biol 19:467-469.
25. Ilieva HS, Yamanaka K, Malkmus S, Kakinohana O, Yaksh T, Marsala M, Cleveland DW. 2008. Mutant dynein (Loa) triggers proprioceptive axon loss that extends survival only in the SOD1 ALS model with highest motor neuron death. Proc Natl Acad Sci U S A. 105:12599-12604.
26. Jaglin XH, Poirier K, Saillour Y, Buhler E, Tian G, Bahi-Buisson N, Fallet-Bianco C, Phan-Dinh-Tuy F, Kong XP, Bomont P, Castelnau-Ptakhine L, Odent S, Loget P, Kossorotoff M, Snoeck I, Plessis G, Parent P, Beldjord C, Cardoso C, Represa A, Flint J, Keays DA, Cowan NJ, Chelly J. 2009. Mutations in the beta-tubulin gene TUBB2B result in asymmetrical polymicrogyria. Nat Genet. 41:746-752.
27. Kaech S, Banker G. 2006. Culturing hippocampal neurons. Nat Protoc 1:2406-2415.
28. Kardon JR, Vale RD. 2009. Regulators of the cytoplasmic dynein motor. Nat Rev Mol Cell Biol 10:854-865.
29. Karki S, Holzbaur EL. 1995. Affinity chromatography demonstrates a direct binding between cytoplasmic dynein and the dynactin complex. J Biol Chem 270:28806-28811.
30. Karki S, Holzbaur EL. 1999. Cytoplasmic dynein and dynactin in cell division and intracellular transport. Curr Opin Cell Biol 11:45-53.
31. Keays DA. 2007. Neuronal migration: Unraveling the molecular pathway with humans, mice, and a fungus. Mamm Genome. 18:425-430.
32. Keays DA, Tian G, Poirier K, Huang GJ, Siebold C, Cleak J, Oliver PL, Fray M, Harvey RJ, Molnar Z, Pinon MC, Dear N, Valdar W, Brown SD, Davies KE, Rawlins JN, Cowan NJ, Nolan P, Chelly J, Flint J. 2007. Mutations in alpha-tubulin cause abnormal neuronal migration in mice and lissencephaly in humans. Cell 128:45-57.
33. Kim H, Ling SC, Rogers GC, Kural C, Selvin PR, Rogers SL, Gelfand VI. 2007. Microtubule binding by dynactin is required for microtubule organization but not cargo transport. J Cell Biol 176:641-651.
34. King SJ, Brown CL, Maier KC, Quintyne NJ, Schroer TA. 2003. Analysis of the dynein-dynactin interaction in vitro and in vivo. Mol Biol Cell 14:5089-5097.
35. Kini AR, Collins CA. 2001. Modulation of cytoplasmic dynein ATPase activity by the accessory subunits. Cell Motil Cytoskeleton 48:52-60.
36. Kono K, Saeki Y, Yoshida S, Tanaka K, Pellman D. 2012. Proteasomal degradation resolves competition between cell polarization and cellular wound healing. Cell 150:151-164.
37. Kuta A, Deng W, Morsi El-Kadi A, Banks GT, Hafezparast M, Pfister KK, Fisher EM. 2010. Mouse cytoplasmic dynein intermediate chains: Identification of new isoforms, alternative splicing and tissue distribution of transcripts. PloS One. 5:e11682.
38. Lai C, Lin X, Chandran J, Shim H, Yang WJ, Cai H. 2007. The G59S mutation in p150(glued) causes dysfunction of dynactin in mice. J Neurosci 27:13982-13990.
39. Lambrechts D, Robberecht W, Carmeliet P. 2007. Heterogeneity in motoneuron disease. Trends Neurosci. 30:536-544.
40. LaMonte BH, Wallace KE, Holloway BA, Shelly SS, Ascano J, Tokito M, Van Winkle T, Howland DS, Holzbaur EL. 2002. Disruption of dynein/dynactin inhibits axonal transport in motor neurons causing late-onset progressive degeneration. Neuron 34:715-727.
41. Lloyd TE, Machamer J, O'Hara K, Kim JH, Collins SE, Wong MY, Sahin B, Imlach W, Yang Y, Levitan ES, McCabe BD, Kolodkin AL. 2012. The p150(glued) CAP-Gly domain regulates initiation of retrograde transport at synaptic termini. Neuron 74:344-360.
42. Lo KW, Kan HM, Pfister KK. 2006. Identification of a novel region of the cytoplasmic dynein intermediate chain important for dimerization in the absence of the light chains. J Biol Chem 281:9552-9559.
43. Maday S, Wallace KE, Holzbaur EL.2012. Autophagosomes initiate distally and mature during transport toward the cell soma in primary neurons. J Cell Biol 196:407-417.
44. Markus SM, Plevock KM, St Germain BJ, Punch JJ, Meaden CW, Lee WL. 2011. Quantitative analysis of Pac1/LIS1-mediated dynein targeting: Implications for regulation of dynein activity in budding yeast. Cytoskeleton (Hoboken). 68:157-174.
45. Matta A, Siu KM, Ralhan R. 14-3-3 zeta as novel molecular target for cancer therapy. Expert Opin Ther Target, in press.
46. McKenney RJ, Weil SJ, Scherer J, Vallee RB. 2011. Mutually exclusive cytoplasmic dynein regulation by NudE-Lis1 and dynactin. J Biol Chem 286:39615-39622.
47. Mitchell DJ, Blasier KR, Jeffery ED, Ross MW, Pullikuth AK, Suo D, Park J, Smiley WR, Lo KW, Shabanowitz J, Deppmann CD, Trinidad JC, Hunt DF, Catling AD, Pfister KK. 2012. Trk activation of the ERK1/2 kinase pathway stimulates intermediate chain phosphorylation and recruits cytoplasmic dynein to signaling endosomes for retrograde axonal transport. J Neurosci 32:15495-15510.
48. Moore JK, Cooper JA. 2010. Coordinating mitosis with cell polarity: Molecular motors at the cell cortex. Semin Cell Dev Biol 21:283-289.
49. Moore JK, Sept D, Cooper JA. 2009. Neurodegeneration mutations in dynactin impair dynein-dependent nuclear migration. Proc Natl Acad Sci U S A 106:5147-5152.
50. Morris-Rosendahl DJ, Najm J, Lachmeijer AM, Sztriha L, Martins M, Kuechler A, Haug V, Zeschnigk C, Martin P, Santos M, Vasconcelos C, Omran H, Kraus U, Van der Knaap MS, Schuierer G, Kutsche K, Uyanik G. 2008. Refining the phenotype of alpha-1a tubulin (tuba1a) mutation in patients with classical lissencephaly. Clin Genet 74:425-433.
51. Moughamian AJ, Holzbaur EL. 2012. Dynactin is required for transport initiation from the distal axon. Neuron 74:331-343.
52. Munch C, Sedlmeier R, Meyer T, Homberg V, Sperfeld AD, Kurt A, Prudlo J, Peraus G, Hanemann CO, Stumm G, Ludolph AC. 2004. Point mutations of the p150 subunit of dynactin (DCTN1) gene in ALS. Neurology 63:724-726.
53. Neal CL, Xu J, Li P, Mori S, Yang J, Neal NN, Zhou X, Wyszomierski SL, Yu D. 2012. Overexpression of 14-3-3zeta in cancer cells activates pi3k via binding the p85 regulatory subunit. Oncogene 31:897-906.
54. Pandey JP, Smith DS. 2011. A Cdk5-dependent switch regulates Lis1/Ndel1/dynein-driven organelle transport in adult axons. J Neurosci 31:17207-17219.
55. Pastuhov SI, Fujiki K, Nix P, Kanao S, Bastiani M, Matsumoto K, Hisamoto N. 2012. Endocannabinoid-goalpha signalling inhibits axon regeneration in Caenorhabditis elegans by antagonizing Gqalpha-PKC-JNK signalling. Nat Commun 3:1136.
56. Penney DP, Powers JM, Frank M, Willis C, Churukian C. 2002. Analysis and testing of biological stains-the biological stain commission procedures. Biotech Histochem 77:237-275.
57. Perlson E, Hanz S, Ben-Yaakov K, Segal-Ruder Y, Seger R, Fainzilber M. 2005. Vimentin-dependent spatial translocation of an activated map kinase in injured nerve. Neuron 45:715-726.
58. Perlson E, Jeong GB, Ross JL, Dixit R, Wallace KE, Kalb RG, Holzbaur EL. 2009. A switch in retrograde signaling from survival to stress in rapid-onset neurodegeneration. J Neurosci 29:9903-9917.
59. Perlson E, Maday S, Fu MM, Moughamian AJ, Holzbaur EL. 2010. Retrograde axonal transport: Pathways to cell death? Trends Neurosci 33:335-344.
60. Pfister KK, Salata MW, Dillman JF, 3rd, Vaughan KT, Vallee RB, Torre E, Lye RJ. 1996. Differential expression and phosphorylation of the 74-kDa intermediate chains of cytoplasmic dynein in cultured neurons and glia. J Biol Chem 271:1687-1694.
61. Pfister KK, Fisher EM, Gibbons IR, Hays TS, Holzbaur EL, McIntosh JR, Porter ME, Schroer TA, Vaughan KT, Witman GB, King SM, Vallee RB. 2005. Cytoplasmic dynein nomenclature. J Cell Biol 171:411-413.
62. Plamann M, Minke PF, Tinsley JH, Bruno KS. 1994. Cytoplasmic dynein and actin-related protein arp1 are required for normal nuclear distribution in filamentous fungi. J Cell Biol 127:139-149.
63. Poirier K, Keays DA, Francis F, Saillour Y, Bahi N, Manouvrier S, Fallet-Bianco C, Pasquier L, Toutain A, Tuy FP, Bienvenu T, Joriot S, Odent S, Ville D, Desguerre I, Goldenberg A, Moutard ML, Fryns JP, van Esch H, Harvey RJ, Siebold C, Flint J, Beldjord C, Chelly J. 2007. Large spectrum of lissencephaly and pachygyria phenotypes resulting from de novo missense mutations in tubulin alpha 1A (Tuba1A). Hum Mutat 28:1055-1064.
64. Puls I, Jonnakuty C, LaMonte BH, Holzbaur EL, Tokito M, Mann E, Floeter MK, Bidus K, Drayna D, Oh SJ, Brown RH, Jr., Ludlow CL, Fischbeck KH. 2003. Mutant dynactin in motor neuron disease. Nat Genet 33:455-456.
65. Puls I, Oh SJ, Sumner CJ, Wallace KE, Floeter MK, Mann EA, Kennedy WR, Wendelschafer-Crabb G, Vortmeyer A, Powers R, Finnegan K, Holzbaur EL, Fischbeck KH, Ludlow CL. 2005. Distal spinal and bulbar muscular atrophy caused by dynactin mutation. Ann Neurol 57:687-694.
66. Reck-Peterson SL, Vale RD, Gennerich A. 2011. Motile properties of cytoplasmic dynein. In: Hirose K, Amos L, editors. Handbook of Dynein. Singapore: Pan Stanford Publishing.
67. Reiner O, Sapoznik S, Sapir T. 2006. Lissencephaly 1 linking to multiple diseases: Mental retardation, neurodegeneration, schizophrenia, male sterility, and more. Neuromol Med 8:547-565.
68. Ross JL, Wallace K, Shuman H, Goldman YE, Holzbaur EL. 2006. Processive bidirectional motion of dynein-dynactin complexes in vitro. Nat Cell Biol 8:562-570.
69. Schroer TA. 2004. Dynactin. Annu Rev Cell Dev Biol 20:759-779.
70. Sheng ZH, Cai Q. 2012. Mitochondrial transport in neurons: Impact on synaptic homeostasis and neurodegeneration. Nat Rev Neurosci 13:77-93.
71. Siman R, McIntosh TK, Soltesz KM, Chen Z, Neumar RW, Roberts VL. 2004. Proteins released from degenerating neurons are surrogate markers for acute brain damage. Neurobiol Dis 16:311-320.
72. Siman R, Giovannone N, Toraskar N, Frangos S, Stein SC, Levine JM, Kumar MA. 2011. Evidence that a panel of neurodegeneration biomarkers predicts vasospasm, infarction, and outcome in aneurysmal subarachnoid hemorrhage. PloS One. 6:e28938.
73. Steinacker P, Aitken A, Otto M. 2011. 14-3-3 proteins in neurodegeneration. Semin Cell Dev Biol 22:696-704.
74. Sweet ES, Firestein BL. 2008. Neuronal polarization: Old cells can learn new tricks. Curr Biol 18:R661-R663.
75. Tischfield MA, Baris HN, Wu C, Rudolph G, Van Maldergem L, He W, Chan WM, Andrews C, Demer JL, Robertson RL, Mackey DA, Ruddle JB, Bird TD, Gottlob I, Pieh C, Traboulsi EI, Pomeroy SL, Hunter DG, Soul JS, Newlin A, Sabol LJ, Doherty EJ, de Uzcategui CE, de Uzcategui N, Collins ML, Sener EC, Wabbels B, Hellebrand H, Meitinger T, de Berardinis T, Magli A, Schiavi C, Pastore-Trossello M, Koc F, Wong AM, Levin AV, Geraghty MT, Descartes M, Flaherty M, Jamieson RV, Moller HU, Meuthen I, Callen DF, Kerwin J, Lindsay S, Meindl A, Gupta ML, Jr., Pellman D, Engle EC. 2010. Human TUBB3 mutations perturb microtubule dynamics, kinesin interactions, and axon guidance. Cell 140:74-87.
76. Tokito MK, Howland DS, Lee VM, Holzbaur EL. 1996. Functionally distinct isoforms of dynactin are expressed in human neurons. Mol Biol Cell 7:1167-1180.
77. Trokter M, Mucke N, Surrey T. 2012. Reconstitution of the human cytoplasmic dynein complex. Proc Natl Acad Sci U S A 109:20895-20900.
78. Tsai LH, Gleeson JG. 2005. Nucleokinesis in neuronal migration. Neuron 46:383-388.
79. Twelvetrees AE, Yuen EY, Arancibia-Carcamo IL, MacAskill AF, Rostaing P, Lumb MJ, Humbert S, Triller A, Saudou F, Yan Z, Kittler JT. 2010. Delivery of GABAARs to synapses is mediated by HAP1-KIF5 and disrupted by mutant huntingtin. Neuron 65:53-65.
80. Tynan SH, Gee MA, Vallee RB. 2000. Distinct but overlapping sites within the cytoplasmic dynein heavy chain for dimerization and for intermediate chain and light intermediate chain binding. J Biol Chem 275:32769-32774.
81. Vallee RB, McKenney RJ, Ori-McKenney KM. 2012. Multiple modes of cytoplasmic dynein regulation. Nat Cell Biol 14:224-230.
82. Vaughan KT. 2011. Roles of cytoplasmic dynein during mitosis. In: S. M. King, editor. Dyneins: Structure, Biology and Disease. MD Heights, MO: Elsevier.
83. Vaughan KT, Vallee RB. 1995. Cytoplasmic dynein binds dynactin through a direct interaction between the intermediate chains and p150glued. J Cell Biol 131:1507-1516.
84. Villapol S, Yaszemski AK, Logan TT, Sanchez-Lemus E, Saavedra JM, Symes AJ. 2012. Candesartan, an angiotensin II AT(1)-receptor blocker and PPAR-gamma agonist, reduces lesion volume and improves motor and memory function after traumatic brain injury in mice. Neuropsychopharmacology 37:2817-2829.
85. Weedon MN, Hastings R, Caswell R, Xie W, Paszkiewicz K, Antoniadi T, Williams M, King C, Greenhalgh L, Newbury-Ecob R, Ellard S. 2011. Exome sequencing identifies a DYNC1H1 mutation in a large pedigree with dominant axonal Charcot-Marie-Tooth disease. Am J Hum Genet 89:308-312.
86. Wynshaw-Boris A. 2007. Lissencephaly and LIS1: Insights into the molecular mechanisms of neuronal migration and development. Clin Genet 72:296-304.
87. Yang L, Ukil L, Osmani A, Nahm F, Davies J, De Souza CP, Dou X, Perez-Balaguer A, Osmani SA. 2004. Rapid production of gene replacement constructs and generation of a green fluorescent protein-tagged centromeric marker in Aspergillus nidulans. Eukaryot Cell 3:1359-1362.
88. Yang X, Cao W, Zhang L, Zhang W, Zhang X, Lin H. 2012. Targeting 14-3-3zeta in cancer therapy. Cancer Gene Ther 19:153-159.
89. Yeh TY, Quintyne NJ, Scipioni BR, Eckley DM, Schroer TA. 2012. Dynactin's pointed-end complex is a cargo-targeting module. Mol Biol Cell 23:3827-3837.
90. Yi JH, Katagiri Y, Susarla B, Figge D, Symes AJ, Geller HM. 2012. Alterations in sulfated chondroitin glycosaminoglycans following controlled cortical impact injury in mice. J Comp Neurol 520:3295-3313.
91. Yi JY, Ori-McKenney KM, McKenney RJ, Vershinin M, Gross SP, Vallee RB. 2011. High-resolution imaging reveals indirect coordination of opposite motors and a role for LIS1 in high-load axonal transport. J Cell Biol. 195:193-201.
92. Yu F, Wang Z, Tchantchou F, Chiu CT, Zhang Y, Chuang DM. 2012. Lithium ameliorates neurodegeneration, suppresses neuroinflammation, and improves behavioral performance in a mouse model of traumatic brain injury. J Neurotrauma 29:362-374.
93. Zhang J, Yao X, Fischer L, Abenza JF, Penalva MA, Xiang X. 2011. The p25 subunit of the dynactin complex is required for dynein-early endosome interaction. J Cell Biol 193:1245-1255.
94. Zhang Q, Wang F, Cao J, Shen Y, Huang Q, Bao L, Zhu X. 2009. Nudel promotes axonal lysosome clearance and endo-lysosome formation via dynein-mediated transport. Traffic 10:1337-1349.
95. Zhou B, Cai Q, Xie Y, Sheng ZH. 2012. Snapin recruits dynein to BDNF-TrkB signaling endosomes for retrograde axonal transport and is essential for dendrite growth of cortical neurons. Cell Rep 2:42-51.